There is substantial amount of literature on the treatment of substance abuse disorders and co-morbidity available. However, the treatment models employed may not be directly applicable for persons diagnosed with co-morbidities such as social anxiety and substance dependency. There does not appear to be an integrated psychosocial treatment programme for substance abusers to prevent relapses and to reduce social anxiety. The National Epidemiologic Survey on Alcohol and Related Conditions (NESARC) reported form a survey (N = 43,093) that there is a high risk of co-occurring anxiety and substance use disorders. The results further revealed that anxiety disorders were more related to substance dependence (odds ration [OR] = 3.0 – 6.0) than substance abuse (OR = 1.2-1.6). Lubman et al. discuss the co-morbidity’s negative impact on quality of life while reiterate that prevalence of co-morbidity causes serious repercussions.